Curcumin attenuates β-catenin signaling in prostate cancer cells through activation of protein kinase D1.
about
Novel cancer chemotherapy hits by molecular topology: dual Akt and Beta-catenin inhibitorsTargeting beta-catenin signaling to induce apoptosis in human breast cancer cells by z-guggulsterone and Gugulipid extract of Ayurvedic medicine plant Commiphora mukul.Bladder cancer and urothelial impairment: the role of TRPV1 as potential drug target.Cucurbitacin E induces apoptosis of human prostate cancer cells via cofilin-1 and mTORC1Targeting multiple pro-apoptotic signaling pathways with curcumin in prostate cancer cellsExtracellular signal-regulated kinase signaling-mediated induction and interaction of FOXO3a and p53 contribute to the inhibition of nasopharyngeal carcinoma cell growth by curcuminProtein kinase D1 attenuates tumorigenesis in colon cancer by modulating β-catenin/T cell factor activity.Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer.Curcumin and obesity.Curcumin Suppresses Metastasis via Sp-1, FAK Inhibition, and E-Cadherin Upregulation in Colorectal Cancer.The multifaceted role of curcumin in cancer prevention and treatment.Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/β-catenin negative feedback loopEffect of curcumin on the interaction between androgen receptor and Wnt/β-catenin in LNCaP xenografts.Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer.A pilot study on intravesical administration of curcumin for cystitis glandularisFuture directions in the prevention of prostate cancer.Protein kinase D isoforms: new targets for therapy in invasive breast cancers?Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatmentPotential therapeutic targets of Guggulsterone in cancerA combination treatment with DNA methyltransferase inhibitors and suramin decreases invasiveness of breast cancer cellsMolecular mechanisms of curcumin action: gene expression.Molecular mechanisms of curcumin action: signal transduction.Curcumin in various cancers.The strategies to control prostate cancer by chemoprevention approaches.Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.Curcumin inhibits growth of prostate carcinoma via miR-208-mediated CDKN1A activation.Curcumin inhibits proliferation-migration of NSCLC by steering crosstalk between a Wnt signaling pathway and an adherens junction via EGR-1.Curcumin suppresses malignant glioma cells growth and induces apoptosis by inhibition of SHH/GLI1 signaling pathway in vitro and vivo.Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice.Suppression of corneal neovascularization by curcumin via inhibition of Wnt/β-catenin pathway activation.Protein kinase D1 regulates subcellular localisation and metastatic function of metastasis-associated protein 1.Effects of different extracts of curcumin on TPC1 papillary thyroid cancer cell line.Oldhamianoside II inhibits prostate cancer progression via regulation of EMT and the Wnt/β-catenin signaling pathway.Thapsigargin induces apoptosis of prostate cancer through cofilin-1 and paxillin.
P2860
Q28546685-DF438E3F-27AB-435B-99E1-01F75BBB152AQ31125801-63785D1E-70ED-463A-A15E-5705C585FFD0Q33667193-1914A37C-B6AD-4D44-B8B5-AAC723C8A1C7Q33751257-37D237E1-2A6A-4C6D-8548-6D8003064C65Q33812005-C6C0413F-CE12-46B2-847A-0830D4985F0CQ33836475-DBCE1D7A-1C8C-45BF-A808-94097E19F70DQ34334430-118638F2-6FD1-4BF8-8BB8-A69ED62B93E1Q34454413-BB3D65E2-EBC6-4D92-8D98-4207AD190BD8Q34647452-F8D028D4-1444-4F97-8A69-0F1A3B3E5434Q34655592-9AC02E8A-07B7-45B2-B412-506F0B5584ECQ34667865-60364AEB-DECF-4DF4-BC33-4DD84EECF10BQ35654152-B111C6CD-F9A5-46BF-8704-63DD9F11FF89Q36048716-1D640CDB-1C6E-4070-942E-DD195CEC0ED1Q36200052-656E0B31-0DC3-4677-BE2F-3225D8EB851FQ36907988-1CA877C7-A464-4C48-BBC4-139FDA73DE8CQ37279094-4616E196-AFD6-40E5-B57A-6365FC1D7150Q37377802-21E15D1B-F1D9-4F4D-AC4D-F899A522B710Q37662418-A48462AE-7134-4442-BA79-8882A102FD19Q37673329-3451F450-1F81-43BF-A7AE-E550F6FBD462Q37696774-C775783F-5960-4AC1-AE8D-A85561B91ABFQ38045211-F8AB7C05-401F-488E-826B-4EABB1511B49Q38072888-5EC57372-FF28-4E66-BE31-1B6B6B4728F2Q38072890-3E710817-3E26-428A-A96E-DE6338677DF9Q38175776-B1DC2790-B3B0-4CD4-B20A-2E00AF21AF05Q38850077-C54EA6CD-7A46-4492-97A1-D6EB4D592FD7Q38868809-0E808E37-1D3B-4A36-A0A7-24C261E58AF2Q38921106-E011E3D1-81D4-431A-97E8-9564E3810D33Q39069500-5DAC0157-015A-4F1C-924F-25B4823E6F8BQ45947878-AF795D44-77C7-42AD-866D-46FA38DA0502Q47272524-3ECB42DD-E17A-43C8-8157-5653075439BCQ49716048-C76B85ED-83DD-4DDA-A511-1D9029E55CC3Q49963024-7BA06D97-7CCC-4829-B231-9C712CDE1550Q55001642-4989BC5D-321E-4C2C-8E2B-C2DB68166788Q55646216-E364731A-E43C-4DB5-BB9C-ED15CDE65455
P2860
Curcumin attenuates β-catenin signaling in prostate cancer cells through activation of protein kinase D1.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Curcumin attenuates β-catenin ...... tivation of protein kinase D1.
@ast
Curcumin attenuates β-catenin ...... tivation of protein kinase D1.
@en
Curcumin attenuates β-catenin ...... tivation of protein kinase D1.
@nl
type
label
Curcumin attenuates β-catenin ...... tivation of protein kinase D1.
@ast
Curcumin attenuates β-catenin ...... tivation of protein kinase D1.
@en
Curcumin attenuates β-catenin ...... tivation of protein kinase D1.
@nl
prefLabel
Curcumin attenuates β-catenin ...... tivation of protein kinase D1.
@ast
Curcumin attenuates β-catenin ...... tivation of protein kinase D1.
@en
Curcumin attenuates β-catenin ...... tivation of protein kinase D1.
@nl
P2093
P2860
P1433
P1476
Curcumin attenuates β-catenin ...... tivation of protein kinase D1.
@en
P2093
Mara Ebeling
Meena Jaggi
Subhash C Chauhan
Vasudha Sundram
P2860
P304
P356
10.1371/JOURNAL.PONE.0035368
P407
P577
2012-04-16T00:00:00Z